Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications E. Caronna; V. José Gallardo; A. Alpuente; M. Torres-Ferrus; N.M. Sánchez-Mateo; J. Viguera-Romero; A.C. López-Veloso; A. López-Bravo; A.B. Gago-Veiga; P. Irimia Sieira; J. Porta-Etessam; S. Santos-Lasaosa; P. Pozo-Rosich;

Headache as a reason for consultation: the primary care perspective A. López-Bravo; E. Bellosta-Diago; A. Viloria-Alebesque; M. Marín-Gracia; J. Laguna-Sarriá; S. Santos-Lasaosa;

Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine S. Santos-Lasaosa; M.L. Cuadrado; A.B. Gago-Veiga; A.L. Guerrero-Peral; P. Irimia; J.M. Láinez; R. Leira; J. Pascual; J. Porta-Etessam; M. Sánchez del Río; J. Viguera Romero; P. Pozo-Rosich;